Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Trellus Health. (TRLS) Share News

Trellus inflammatory bowel disease product offered via NY Medicaid

13th Feb 2023 10:51

(Alliance News) - Trellus Health PLC on Monday said its resilience training and self-management solution for inflammatory bowel disease will be available under an initial trial with a health insurance company operating in the US state of New York. Read More

Trellus inflammatory bowel disease product offered via NY Medicaid

13th Feb 2023 10:43

EKF Diagnostics restructures leadership; shifts focus away from Covid

6th Feb 2023 11:34

(Alliance News) - EKF Diagnostics Holdings PLC on Monday said it anticipates its 2022 earnings will be below market expectations as it shifts its focus away from Covid-19, while it also announced that its chief executive officer and chair are stepping down from their roles. Read More

IN BRIEF: Trellus Health stock sinks after disappointing 2022 guidance

20th Dec 2022 14:40

Trellus Health PLC - New York-based digital health platform provider - Expects "modest" revenue and a loss of earnings before interest, taxes, depreciation and amortisation loss to be in line with expectations for 2022. As at December 31, net cash position is seen totaling no less than USD18 million, slightly better than expected. Expects its cash runway to extend into 2025. Read More

TRADING UPDATES: IQE, Trellus Health and Insig sign new agreements

17th Oct 2022 16:31

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: Trellus Health interim loss widens but optimistic for future

5th Oct 2022 06:55

Trellus Health PLC - New York-based digital health platform provider - Last Friday notes interim loss widens as firm is still in development phase but remains funded into at least 2025. Pretax loss in the half-year that ended June 30 widens to USD4.8 million from USD1.6 million a year prior. Virtually all of loss in either period are administrative expenses. Revenue at USD10,000 versus none. "The group is in the development phase of its business and has only generated revenues related to implementation services totalling USD10,000," company explains. Read More

FTSE 100 Latest

Value8,774.65

Change-17.15